Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Intestinal Neoplasms × ABT-165 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Intestinal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Radiotherapy 2 Oxaliplatin 2 Fluorouracil 2 Bevacizumab 2 Artesunate 2 camrelizumab 1 apatinib 1 XELOX 1 Trastuzumab 1 Ocoxin 1 Leucovorin 1 Irinotecan 1 Folfox protocol 1 Drug Therapy 1 Chemoradiotherapy 1 Capecitabine 1 ABT-165 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03368859 2021-02-09

A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

AbbVie

Phase 2 Terminated

70 enrolled 12 charts

Gastrointestinal

Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡